Search clinical trials for: Semaglutide, 1.34 mg/mL

Total 1095 results

Novo Nordisk A/S

Completed

A Research Trial Looking at the Comparability of 2 Different Concentrations of Semaglutide for the 0.5 Milligram (mg) Dose

Diabetes Mellitus, Type 2 | Healthy Participants

United States
Novo Nordisk A/S

Completed

A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People

Diabetes Mellitus, Type 2

Germany
Novo Nordisk A/S

Completed

A Clinical Trial Looking at the Comparability of 2 Different Forms of Semaglutide

Healthy Volunteers (Diabetes Mellitus, Type 2)

United Kingdom
Kirsi Pietiläinen
Turku University Hospital; University of Helsinki

Recruiting

Semaglutide as an Adjunct to Dieting in the Treatment of Type 2 Diabetes (MitoSema)

Type2 Diabetes

Finland
Novo Nordisk A/S

Completed

A Research Study to Look at Similarity Between Semaglutide Versions in Different Injection Tools

Diabetes Mellitus, Type 2

Germany
Jan Frystyk
Region of Southern Denmark; Region Zealand; Steno Diabetes Center Sjaelland; Steno...

Recruiting

Home-based Intervention With Semaglutide Treatment Of Neuroleptica-Related Prediabetes (HISTORI)

Schizophrenia | Prediabetic State

Denmark
Steno Diabetes Center Copenhagen
Novo Nordisk A/S

Unknown

Renal Effects of Treatment With Empagliflozin Alone or in Combination With Semaglutide in Patients With Type 2 Diabetes and Albuminuria (EmpaSema)

Type 2 Diabetes With Renal Manifestations

Denmark
Merck Sharp & Dohme LLC

Completed

A Study of Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001)

Nonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis

United States, Argentina, Australia, Canada, France, Israel, Italy, Korea, Republic of, Mexico, New Zealand, Poland, Russian Federation, Spain, Taiwan, Turkey, Ukraine
Peking University First Hospital

Recruiting

Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome

Semaglutide | PCOS (Polycystic Ovary Syndrome)

China
Filip Krag Knop

Recruiting

The Separate and Combined Effects of Long-term GIP and GLP-1 Receptor Activation in Patients With Type 2 Diabetes

Obesity | Type 2 Diabetes

Denmark
Geisinger Clinic

Terminated

Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy (RAISE-KT)

Obesity | Diabetic Kidney Disease | Type 2 Diabetes Mellitus in Obese | CKD | Severe Obesity

United States
Anders Fink-Jensen, MD, DMSci

Recruiting

Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?

Schizophrenia | Type 2 Diabetes | Metabolic Disturbance | Clozapine | Olanzapine | GLP-1

Denmark
Rijnstate Hospital

Not yet recruiting

DUTCH Weight Control in Atrial Fibrillation Study (DUTCH-WAIST)

Obesity | Atrial Fibrillation | Weight Loss
Novo Nordisk A/S

Completed

A Research Study Comparing Blood Levels of Medicines NNC0194-0499 and Semaglutide Administered as a Combination Formulation Versus Two Separate Formulations

Non-alcoholic Steatohepatitis

Canada
Novo Nordisk A/S

Completed

A Research Study Looking Into the Effect of Semaglutide and NNC0480 0389 on Blood Levels of a Birth Control Pill in Woman After Menopause

Diabetes Mellitus, Type 2

Germany
Academisch Medisch Centrum - Universiteit van Amsterdam...
Dutch Heart Foundation

Recruiting

Does the Hematopoietic Stem Cell Govern Residual Inflammatory Cardiovascular Risk in Type 2 Diabetes (DOTAFLAME)

Type 2 Diabetes

Netherlands
Novo Nordisk A/S

Active, not recruiting

Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH)

Non-alcoholic Steatohepatitis

Spain, Denmark, Taiwan, Korea, Republic of, Australia, Canada, India, Singapore, United States, Turkey, Poland, Italy, Belgium, Puerto Rico, United Kingdom, Malaysia, Germany, Portugal, Bulgaria, Czechia, France, Greece, Japan, Russian...
Zuyderland Medisch Centrum
Nederlandse Obestias Kliniek (NOK)

Not yet recruiting

Semaglutide 2.4mg for Low Responders After Bariatric Surgery (SEABAR)

Obesity | Obesity, Morbid | Weight Gain
Novo Nordisk A/S

Completed

Research Study Comparing Different Tablets With the Study Medicine Semaglutide in Healthy Men

Diabetes Mellitus, Type 2

Germany
Novo Nordisk A/S

Completed

A Trial to Assess the Pharmacokinetics, Safety and Tolerability of Semaglutide in Healthy Chinese Subjects

Diabetes Mellitus, Type 2 | Diabetes

China
Sansum Diabetes Research Institute
Novo Nordisk A/S

Terminated

Comparison of Oral Semaglutide w/ Placebo- Treatment for Latino Adults w/T2 Diabetes Receiving Enhanced Lifestyle Care

Diabetes Mellitus, Type 2 | Glucose Metabolism Disorders (Including Diabetes Mellitus)

United States
Novo Nordisk A/S

Completed

Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or Obesity (STEP 2)

Obesity | Overweight

United States, India, Japan, Russian Federation, United Kingdom, Canada, Spain, South Africa, Germany, Greece, United Arab Emirates, Argentina, Puerto Rico
Academisch Medisch Centrum - Universiteit van Amsterdam...
Endogenex

Recruiting

A Trial to Evaluate Safety, Feasibility and Efficacy of the ReCET Procedure (EMINENT-2) (EMINENT-2)

Diabetes Mellitus, Type 2

Netherlands
Microbiome Health Sciences

Completed

Tolerability Study of Panosyl-Isomaltooligosaccharides (PIMO) and a Placebo in Subjects With Heartburn

Heartburn

United States
Lundquist Institute for Biomedical Innovation at...

Completed

Semaglutide Treatment On Coronary Progression (STOP)

Coronary Artery Disease | Type 2 Diabetes

United States
Novo Nordisk A/S

Completed

A Trial to Compare Blood Concentration Levels of Semaglutide Following Subcutaneous Injections of Semaglutide 1 mg by 2 Different Devices (the DV3372 Device and by the PDS290 Semaglutide Pen-injector)

Diabetes Mellitus, Type 2

Germany
Novo Nordisk A/S

Completed

Research Study Looking at How Well Semaglutide Works in People Suffering From Obesity and Knee Osteoarthritis

Obesity

Spain, United States, France, Russian Federation, Canada, Colombia, South Africa, Norway, Denmark, Saudi Arabia, Sweden
Novo Nordisk A/S

Completed

A Research Study to Investigate How Well NNC0165-1875 in Combination With Semaglutide Works in People With Obesity

Obesity

United States
Novo Nordisk A/S

Completed

Research Study Investigating How Well Semaglutide Works in People From Thailand and South Korea Living With Obesity

Obesity

Korea, Republic of, Thailand
Maimónides Biomedical Research Institute of Córdoba
Consejería de Salud y Familias - Junta de Andalucía; Red Andaluza de Ensayos...

Completed

Clinical Trial of Sarilumab in Adults With COVID-19 (SARICOR)

SARS-CoV 2 | SARS

Spain
Instituto de Investigación Marqués de Valdecilla

Unknown

Effect of Sarilumab on Atherosclerotic Disease Assessed by PET/CET in Patients With RA (SARIPET) (SARIPET)

Rheumatoid Arthritis | Atherosclerosis
Novo Nordisk A/S

Completed

Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in East Asian People Who Are Overweight or Living With Obesity (OASIS 2)

Overweight and Obesity

Japan, Korea, Republic of
Novo Nordisk A/S

Completed

Research Study to Look at How Well Cagrilintide Together With Semaglutide Works in People With Type 2 Diabetes

Diabetes Mellitus, Type 2

United States
POLYSAN Scientific & Technological Pharmaceutical...

Completed

"Unifuzol®" in Patients With Peripheral Arterial Disease

Peripheral Arterial Disease

Russian Federation
University of Tartu

Completed

The Effect of Semaglutide on Pituitary Function

Healthy

Estonia
Novo Nordisk A/S

Completed

Research Study Looking at How Well Semaglutide Works in People Living With Obesity and Prediabetes (STEP 10)

Obesity

United Kingdom, Canada, Denmark, Finland, Spain
University College, London

Active, not recruiting

Semaglutide 2.4 mg in Patients With Poor Weight-loss (BARI-STEP)

Obesity | Diabetes | Metabolic Syndrome

United Kingdom
University of Oxford
NIHR Oxford Health Biomedical Research Centre

Not yet recruiting

Semaglutide and Cognition in Healthy Volunteers (OxSENSE)

Cognitive Change

United Kingdom
AmtixBio Co., Ltd.
Novotech (Australia) Pty Limited

Completed

A Study of ATB1651 in Adults With Mild to Moderate Onychomycosis

Onychomycosis

New Zealand
Geisinger Clinic
Novo Nordisk A/S

Terminated

Treatment of GLP-1 for Diabetic Bariatric Patients (NOVO-GLP1)

Diabetes Mellitus, Type 2

United States
Novo Nordisk A/S

Completed

A Research Study Looking at How 50 mg Semaglutide Daily Affects Food Intake and Emptying of the Stomach in People With Obesity

Obesity

Germany
Rigshospitalet, Denmark
Odense University Hospital; Aarhus University Hospital

Not yet recruiting

Semaglutide Treatment for Hyperglycaemia After Renal Transplantation (Sema-RTx)

Hyperglycemia | Diabetes | Renal Transplant Complication Primary Non-Function
University of Colorado, Denver
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Recruiting

Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder (AUD)

Alcohol Use Disorder

United States
Shaheed Zulfiqar Ali Bhutto Medical University

Completed

Tocilizumab and Cytokine Release Syndrome (CRS) In Covid-19 Pneumonia

Cytokine Release Syndrome | Covid-19 Pneumonia

Pakistan
Endo Pharmaceuticals

Completed

AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder

Adhesive Capsulitis | Frozen Shoulder

United States
Hamlet Pharma AB

Recruiting

A First-in-Human Study of alpha1H in Patients With Non-muscle Invasive Bladder Cancer

Non-muscle Invasive Bladder Cancer

Czechia
Auris Medical AG

Completed

AM-111 in the Treatment of Acute Inner Ear Hearing Loss (HEALOS)

Hearing Loss

Bulgaria
Adynxx, Inc.
National Institute on Drug Abuse (NIDA)

Withdrawn

Study to Evaluate a Preop Dose of Brivoligide Injection for Pain After Mastectomy in Patients With High PCS Scores

Pain, Postoperative
Jadran Galenski laboratorij d.d.

Completed

Comparative Study of Dorzotimol Eye Drops, 20 mg/mL + 5 mg/mL Versus Cosopt® Eye Drops, 20 mg/mL + 5 mg/mL

Primary Open Angle Glaucoma of Both Eyes

Russian Federation
Novo Nordisk A/S

Completed

Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT) (SUSTAIN)

Diabetes Mellitus, Type 2 | Diabetes

Taiwan, Korea, Republic of, South Africa, Hong Kong, Brazil, China, Ukraine

Search clinical trials for: Semaglutide, 1.34 mg/mL

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations